Browsing Pharmacy Research by Subject "CDKN3"
Now showing items 1-1 of 1
-
Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis
( Lippincott Williams and Wilkins , 2023 , Article)Cell cycle regulatory proteins plays a pivotal role in the development and progression of many human malignancies. Identification of their biological functions as well as their prognostic utility presents an active field ...